‘Unprecedented’ CAR-T results for lupus net Insight prize for researchers

Two scientists whose work sparked industry excitement about the prospect of using chimeric antigen receptor T cell (CAR-T) therapy for autoimmune disease are the recipients of the Lupus Research Alliance’s annual prize for scientific discoveries.

They plan to use the funds to make the treatment more effective, according to the nonprofit research organization.

Georg Schett, M.D., of Germany’s Friedrich-Alexander-Universität Erlangen-Nürnberg and Marko Radic, Ph.D., of the University of Tennessee Health Science Center in Memphis, were presented with the 2024 Lupus Insight Prize during a June 19 ceremony at the Federation of Clinical Immunology Societies meeting in San Francisco. The $100,000 award is given to scientists who have made significant discoveries within the past five years. 

“The importance of the CD19 CAR-T cell therapy research led by [Schett and Radic] lies in the dramatic and unprecedented to date clinical results in the few treated patients within Dr. Schett’s trial showing…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks